Safety and Immunogenicity of a Booster Dose of GSK Biological's Boostrix-Polio Vaccine

Clinical trial NCT00635128 · COMPLETED

Trial details

NCT number: NCT00635128
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Poliomyelitis Diphtheria Tetanus Acellular Pertussis

Start date: 2008-02-01
Primary completion: 2008-07-08
Enrollment: 415

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.